Glycaemic control and glucose-lowering therapy in diabetic patients with kidney disease

被引：0
|
作者：
Mpondo, B. [1 ]
机构：
[1] Univ Dodoma, Coll Hlth Sci, Dept Internal Med, Dodoma, Tanzania
来源：
AFRICAN JOURNAL OF DIABETES MEDICINE | 2014年 / 22卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：12 / 16
页数：5
相关论文
共 50 条
  • [31] Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients
    Yeoh, Ester
    Lim, Boon Khim
    Fun, Sharon
    Tong, Julia
    Yeoh, Lee Ying
    Sum, Chee Fang
    Subramaniam, Tavintharan
    Lim, Su Chi
    [J]. NEPHROLOGY, 2018, 23 (03) : 264 - 268
  • [32] Hypoglycemia risk with inappropriate dosing of glucose-lowering drugs in patients with chronic kidney disease: a retrospective cohort study
    Li, Yun-Jhe
    Chang, Yuh-Lih
    Chou, Yueh-Ching
    Hsu, Chia-Chen
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [33] Impact of cancer diagnosis and treatment on glycaemic control among individuals with colorectal cancer using glucose-lowering drugs
    Marjolein M. J. Zanders
    Myrthe P. P. van Herk-Sukel
    Ron M. C. Herings
    Lonneke V. van de Poll-Franse
    Harm R. Haak
    [J]. Acta Diabetologica, 2016, 53 : 727 - 735
  • [34] Dispensing Pattern of Blood Glucose-Lowering Drugs in New Diabetic Patients in Real Practice
    Ferrajolo, Carmen
    Trifiro, Gianluca
    Giorgianni, Francesco
    Rafaniello, Concetta
    Sportiello, Liberata
    Arcoraci, Vincenzo
    Pozzuoli, Giuseppe
    Pagliaro, Claudia
    Linguiti, Claudio
    Tari, Daniele U.
    Caputi, Achille P.
    Rossi, Francesco
    Giugliano, Dario
    Esposito, Katherine
    Capuano, Annalisa
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 464 - 465
  • [35] Impact of cancer diagnosis and treatment on glycaemic control among individuals with colorectal cancer using glucose-lowering drugs
    Zanders, Marjolein M. J.
    van Herk-Sukel, Myrthe P. P.
    Herings, Ron M. C.
    van de Poll-Franse, Lonneke V.
    Haak, Harm R.
    [J]. ACTA DIABETOLOGICA, 2016, 53 (05) : 727 - 735
  • [36] Glycaemic control in 163 121 patients with type 2 diabetes on different glucose-lowering treatments: nationwide cross-sectional survey
    Gudbjornsdottir, S.
    Miftaraj, M.
    Svensson, A. -M.
    Cederholm, J.
    Ekstrom, N.
    Zethelius, B.
    Eliasson, B.
    [J]. DIABETOLOGIA, 2011, 54 : S160 - S160
  • [37] Development and Validation of a Measure for Appropriateness of Glucose-Lowering Therapy
    McCoy, Rozalina G.
    Lipska, Kasia J.
    Van Houten, Holly
    Shah, Nilay
    [J]. DIABETES, 2019, 68
  • [38] Intensive glucose-lowering therapy—weighing up the evidence
    Neale Cohen
    [J]. Nature Reviews Endocrinology, 2010, 6 : 9 - 10
  • [39] The cardiovascular phenotype: impact on choice of glucose-lowering therapy
    Kalra, Sanjay
    Gupta, Yashdeep
    Kishor, Kamal
    [J]. JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2016, 66 (04) : 480 - 482
  • [40] Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose-lowering interventions
    Roussel, Ronan
    Steg, Philippe Gabriel
    Mohammedi, Kamel
    Marre, Michel
    Potier, Louis
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (02): : 238 - 244
12345